Submitted by Eric Maus on October 1, 2025 - 17:11
Rather than adopting MFN, the administration and Congress should reject price controls, reform 340B, and eliminate CMMI
Submitted by Eric Maus on October 1, 2025 - 17:11 1759353101
AB 1460 would change how the federal 340B Drug Pricing Program operates in the Golden State
The 340B Drug Pricing Program has been used to inflate the profits of hospitals and pharmacies rather than providing savings.
Submitted by Eric Maus on April 18, 2025 - 16:14
This Week in Waste highlights how taxpayer dollars are being wasted and efforts to fight back against this waste.
Submitted by Eric Maus on April 18, 2025 - 16:14 1745007259
Submitted by Thomas Schatz on April 16, 2025 - 17:32
President Trump's EO addresses the dual objectives of lowering drug prices while promoting innovation and protecting IP
Submitted by Thomas Schatz on April 16, 2025 - 17:32 1744839152
HB 1150 would lead to the loss of more than 135 brick and mortar retail pharmacies in the state and eliminate associated cost-saving mail order and specialty pharmacy options.
HB 1724 would impose price controls on prescription drugs.
SB 45, SB 372, and SB 512 would create unnecessary regulatory barriers that will undermine the effectiveness of pharmacy benefit managers in Missouri and increase prescription drug costs for patients.
